Article
Orlando, FL-A new analysis of data from the National Cancer Institute'snationwide Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screeningtrial suggests that annual PSA screening may not be necessary for many men.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
Vaginal prolapse repair and sling surgery significantly reduce UUI
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
FDA grants marketing authorization to at-home diagnostic test for STIs
Expert discusses unique mechanism of action of UTI treatment gepotidacin
ASCO 2025: What to watch for in GU oncology
FDA awards Regenerative Medicine Advanced Therapy Designation to CAN-2409 for prostate cancer
Intraprostatic drug elution therapy shows promise for BPH-related LUTS
Subcutaneous nivolumab approved in EU, Canada for solid tumors